Patient Home
Welcome to Health Vidya. Discover trusted care and your own health — all in one place.
These highlights do not include all the information needed to use SUSTIVA safely and effectively. See full prescribing information for SUSTIVA. SUSTIVA® (efavirenz) capsules for oral useSUSTIVA® (efavirenz) tablets for oral useInitial U.S. Approval: 1998
Medication labelWhy this: Advisory · dailymed-prescription
SUSTIVA® (efavirenz) in combination with other antiretroviral agents is indicated for the treatment of human immunodeficiency virus type 1 (HIV-1) infection. This indication is based on two clinical trials of at least one year duration that demonstrated prolonged suppression of HIV RNA [see Clinical Studies (14) ].
- generic_name
- efavirenz
- product_names
- efavirenz
- ndc
- 54868-4668, 0056-0510, 54868-4668-0
- group
- drugs
- license
- us-gov-pd
- attribution
- Courtesy of the National Library of Medicine
- reviewed
- 2026-09-18
- language
- en